Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease

Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease

Glucocorticoid excess is a known risk factor for non-alcoholic fatty liver disease (NAFLD). Our objective was to analyse the impact of glucocorticoid replacement therapy on the development of NAFLD and NAFLD-related fibrosis and, therefore, on cardiovascular as well as hepatic morbidity in patients...

Full description

Bibliographic Details
Main Authors: Gesine Meyer, Madeleine Gruendl, Irina Chifu, Stefanie Hahner, Johanna Werner, Johannes Weiß, Tina Kienitz, Marcus Quinkler, Klaus Badenhoop, Eva Herrmann, Mireen Friedrich-Rust, Joerg Bojunga
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Clinical Medicine
Subjects:
adrenal insufficiency
glucocorticoid replacement
non-alcoholic fatty liver disease
elastography
hepatic steatosis
hepatic fibrosis
Online Access:https://www.mdpi.com/2077-0383/12/19/6392

Internet

https://www.mdpi.com/2077-0383/12/19/6392

Similar Items